Nuveen LLC Invests $3.36 Million in Trupanion, Inc. $TRUP

Key Points

• Nuveen LLC has invested approximately $3.36 million in Trupanion, purchasing 90,213 shares during Q1, which represents about 0.21% of the company's stock.
• Trupanion recently reported earnings per share (EPS) of $0.22, surpassing consensus estimates and marking a revenue increase of 12.3% year-over-year.
• Equities analysts have revised their price targets for Trupanion, with the consensus target now set at $54.17, reflecting a "Moderate Buy" rating.

Nuveen LLC purchased a new stake in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 90,213 shares of the financial services provider's stock, valued at approximately $3,362,000. Nuveen LLC owned about 0.21% of Trupanion at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Palisade Capital Management LP lifted its holdings in Trupanion by 36.7% during the 1st quarter. Palisade Capital Management LP now owns 244,354 shares of the financial services provider's stock valued at $9,107,000 after purchasing an additional 65,653 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in Trupanion by 112.2% in the 4th quarter. Dimensional Fund Advisors LP now owns 273,910 shares of the financial services provider's stock valued at $13,204,000 after buying an additional 144,828 shares in the last quarter. Northern Trust Corp grew its holdings in Trupanion by 9.0% in the 4th quarter. Northern Trust Corp now owns 368,236 shares of the financial services provider's stock valued at $17,749,000 after buying an additional 30,549 shares in the last quarter. Balyasny Asset Management L.P. grew its holdings in Trupanion by 368.2% in the 4th quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider's stock valued at $40,548,000 after buying an additional 661,559 shares in the last quarter. Finally, Banque Pictet & Cie SA acquired a new position in Trupanion in the 1st quarter valued at $439,000.

Insider Buying and Selling

In other Trupanion news, CFO Fawwad Qureshi sold 2,800 shares of the stock in a transaction dated Tuesday, August 26th. The stock was sold at an average price of $45.56, for a total value of $127,568.00. Following the completion of the transaction, the chief financial officer directly owned 6,451 shares in the company, valued at approximately $293,907.56. This trade represents a 30.27% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 5.42% of the company's stock.

Trupanion Price Performance

Shares of TRUP stock traded down $1.16 on Tuesday, hitting $45.20. 479,147 shares of the company's stock were exchanged, compared to its average volume of 553,317. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.69 and a quick ratio of 1.69. Trupanion, Inc. has a 12 month low of $31.00 and a 12 month high of $57.90. The stock has a market cap of $1.94 billion, a P/E ratio of 173.85 and a beta of 1.72. The company has a 50 day moving average of $49.68 and a 200 day moving average of $44.01.

Trupanion (NASDAQ:TRUP - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The financial services provider reported $0.22 earnings per share for the quarter, topping the consensus estimate of ($0.03) by $0.25. Trupanion had a return on equity of 3.31% and a net margin of 0.81%.The business had revenue of $353.56 million during the quarter, compared to the consensus estimate of $346.73 million. During the same period in the prior year, the company earned ($0.14) EPS. Trupanion's revenue for the quarter was up 12.3% on a year-over-year basis. Trupanion has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, equities research analysts predict that Trupanion, Inc. will post 0.13 EPS for the current year.

Analysts Set New Price Targets

A number of research analysts have commented on TRUP shares. Piper Sandler upped their price objective on Trupanion from $62.00 to $67.00 and gave the company an "overweight" rating in a report on Friday, August 8th. Stifel Nicolaus upped their price objective on Trupanion from $41.00 to $45.00 and gave the company a "hold" rating in a report on Friday, August 8th. Finally, Cantor Fitzgerald raised Trupanion to a "hold" rating in a report on Wednesday, August 13th. Three equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $54.17.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.